260 related articles for article (PubMed ID: 7572913)
1. Control of gastric acid with high dose H2-receptor antagonists after omeprazole failure: report of two cases.
Leite LP; Just RJ; Castell DO; Lagerström PO
Am J Gastroenterol; 1995 Oct; 90(10):1874-7. PubMed ID: 7572913
[TBL] [Abstract][Full Text] [Related]
2. [25 years of gastric acid blockers].
Lamers CB
Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2501-4. PubMed ID: 10627749
[TBL] [Abstract][Full Text] [Related]
3. Efficacy, safety, and cost issues in managing patients with gastroesophageal reflux disease.
Garnett WR
Am J Hosp Pharm; 1993 Apr; 50(4 Suppl 1):S11-8. PubMed ID: 8097363
[TBL] [Abstract][Full Text] [Related]
4. [Gastroesophageal reflux (round table I)].
Caussignac Y; Martin S; Jobin G; Beauchamp G
Union Med Can; 1995 Mar; 124(1):26-31. PubMed ID: 8540149
[No Abstract] [Full Text] [Related]
5. Omeprazole in Zollinger-Ellison syndrome. Effects of a single dose and of long-term treatment in patients resistant to histamine H2-receptor antagonists.
Lambers CB; Lind T; Moberg S; Jansen JB; Olbe L
N Engl J Med; 1984 Mar; 310(12):758-61. PubMed ID: 6142418
[TBL] [Abstract][Full Text] [Related]
6. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
Florent C
Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
[TBL] [Abstract][Full Text] [Related]
7. Can optimal acid suppression prevent rebleeding in peptic ulcer patients with a non-bleeding visible vessel: a preliminary report of a randomized comparative study.
Lin HJ; Lo WC; Perng CL; Wang K; Lee FY
Hepatogastroenterology; 1997; 44(17):1495-9. PubMed ID: 9356879
[TBL] [Abstract][Full Text] [Related]
8. Persistent acid secretion during omeprazole therapy: a study of gastric acid profiles in patients demonstrating failure of omeprazole therapy.
Leite LP; Johnston BT; Just RJ; Castell DO
Am J Gastroenterol; 1996 Aug; 91(8):1527-31. PubMed ID: 8759655
[TBL] [Abstract][Full Text] [Related]
9. Omeprazole: a new approach to gastric acid suppression.
Buhl K; Clearfield HR
Am Fam Physician; 1990 Apr; 41(4):1225-7. PubMed ID: 2321497
[TBL] [Abstract][Full Text] [Related]
10. Refractory peptic ulcers.
Arakawa T; Kobayashi K; Dajani EZ
J Assoc Acad Minor Phys; 1992; 3(3):95-102. PubMed ID: 1386767
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician.
Huang JQ; Hunt RH
Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):355-70. PubMed ID: 11403532
[TBL] [Abstract][Full Text] [Related]
12. pH, healing rate, and symptom relief in patients with GERD.
Huang JQ; Hunt RH
Yale J Biol Med; 1999; 72(2-3):181-94. PubMed ID: 10780580
[TBL] [Abstract][Full Text] [Related]
13. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A;
Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
[TBL] [Abstract][Full Text] [Related]
14. The medical management of reflux esophagitis. Role of antacids and acid inhibition.
Sontag SJ
Gastroenterol Clin North Am; 1990 Sep; 19(3):683-712. PubMed ID: 1977703
[TBL] [Abstract][Full Text] [Related]
15. Acid-suppressing drugs during pregnancy.
Lalkin A; Magee L; Addis A; Loebstein R; Koren G
Can Fam Physician; 1997 Nov; 43():1923-4, 1927. PubMed ID: 9386876
[No Abstract] [Full Text] [Related]
16. Histamine H2 receptor antagonist-refractory oesophagitis: the efficacy of long-term omeprazole maintenance treatment.
Bardhan KD; Cherian P; Jones RB; Vaishnavi A; Manek S; Bishop A; Polak J; Brooks A; Morris P; Thompson M; D'Silva J; Parkin S; Patterson J; Gillon KR
Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):515-9. PubMed ID: 9513825
[TBL] [Abstract][Full Text] [Related]
17. Treatment of gastroesophageal (acid) reflux with lansoprazole: an overview.
Dobrilla G; Di Fede F
Clin Ther; 1993; 15 Suppl B():2-13. PubMed ID: 7911400
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in the management of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
Maton PN; Gardner JD; Jensen RT
Gastroenterol Clin North Am; 1989 Dec; 18(4):847-63. PubMed ID: 2575602
[TBL] [Abstract][Full Text] [Related]
19. [H2-blocker refractory ulcers: what can be done?].
Dammann HG
Z Gastroenterol; 1992 Apr; 30(4):268-71. PubMed ID: 1351328
[TBL] [Abstract][Full Text] [Related]
20. [Are proton pump inhibitors superior to H2 receptor antagonists within the scope of H. pylori eradication therapy? Meta analysis of current parallel group comparisons].
Holtmann G; Layer P; Goebell H
Z Gastroenterol; 1996 May; 34(5):267-72. PubMed ID: 8686357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
